|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0018957,
umls-concept:C0030705,
umls-concept:C0032854,
umls-concept:C0036525,
umls-concept:C0038250,
umls-concept:C0205217,
umls-concept:C0332281,
umls-concept:C0332293,
umls-concept:C0740457,
umls-concept:C1176020,
umls-concept:C1274040,
umls-concept:C1522484,
umls-concept:C1561558
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2011-3-30
|
|
pubmed:abstractText |
Haematopoietic progenitor cells (HPCs) are present in blood in metastatic renal cell cancer (mRCC). We investigate their expression in mRCC patients treated with sunitinib and correlate their expression with plasma growth factor levels [insulin-like growth factor (IGF)-1].
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1569-8041
|
|
pubmed:author |
pubmed-author:AgrawalSS,
pubmed-author:BazeosAA,
pubmed-author:BoletiKK,
pubmed-author:ChowdhurySS,
pubmed-author:GillessenSS,
pubmed-author:LieTT,
pubmed-author:NathanPP,
pubmed-author:PetersJJ,
pubmed-author:PowlesTT,
pubmed-author:SaderEE,
pubmed-author:SarwarNN,
pubmed-author:SaundersNN,
pubmed-author:ShamashJJ,
pubmed-author:WilsonPP
|
|
pubmed:copyrightInfo |
© The Author 2010. Published by Oxford University Press on behalf of the European Society for Medical Oncology.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
815-20
|
|
pubmed:meshHeading |
pubmed-meshheading:20943595-Adult,
pubmed-meshheading:20943595-Aged,
pubmed-meshheading:20943595-Antineoplastic Agents,
pubmed-meshheading:20943595-Cell Proliferation,
pubmed-meshheading:20943595-Disease-Free Survival,
pubmed-meshheading:20943595-Female,
pubmed-meshheading:20943595-Hematopoietic Stem Cells,
pubmed-meshheading:20943595-Humans,
pubmed-meshheading:20943595-Indoles,
pubmed-meshheading:20943595-Insulin-Like Growth Factor I,
pubmed-meshheading:20943595-Kidney Neoplasms,
pubmed-meshheading:20943595-Male,
pubmed-meshheading:20943595-Middle Aged,
pubmed-meshheading:20943595-Neoplasm Metastasis,
pubmed-meshheading:20943595-Pyrroles,
pubmed-meshheading:20943595-Treatment Outcome,
pubmed-meshheading:20943595-Tumor Markers, Biological
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Increased haematopoietic progenitor cells are associated with poor outcome in patients with metastatic renal cancer treated with sunitinib.
|
|
pubmed:affiliation |
Centre for Experimental Cancer Medicine, St Bartholomew's Hospital, London, UK. Thomas.powles@bartsandthelondon.nhs.uk
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
